ScholarIQanswers from OpenAlex

Treatment of Tourette's Syndrome with Δ<sup>9</sup>-Tetrahydrocannabinol (THC): A Randomized Crossover Trial

PaperCitations, authors & open-access status

Treatment of Tourette's Syndrome with Δ<sup>9</sup>-Tetrahydrocannabinol (THC): A Randomized Crossover Trial is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Treatment of Tourette's Syndrome with Δ<sup>9</sup>-Tetrahydrocannabinol (THC): A Randomized Crossover Trial have?

ScholarIQcitation count

Treatment of Tourette's Syndrome with Δ<sup>9</sup>-Tetrahydrocannabinol (THC): A Randomized Crossover Trial has 256 citations in the OpenAlex counts ScholarIQ stores.

When was Treatment of Tourette's Syndrome with Δ<sup>9</sup>-Tetrahydrocannabinol (THC): A Randomized Crossover Trial published?

ScholarIQyear

Treatment of Tourette's Syndrome with Δ<sup>9</sup>-Tetrahydrocannabinol (THC): A Randomized Crossover Trial has 2002 year in the ScholarIQ index.

What is the open-access status of Treatment of Tourette's Syndrome with Δ<sup>9</sup>-Tetrahydrocannabinol (THC): A Randomized Crossover Trial?

ScholarIQoa status

Treatment of Tourette's Syndrome with Δ<sup>9</sup>-Tetrahydrocannabinol (THC): A Randomized Crossover Trial has closed oa status in the ScholarIQ index.

What is the DOI of Treatment of Tourette's Syndrome with Δ<sup>9</sup>-Tetrahydrocannabinol (THC): A Randomized Crossover Trial?

ScholarIQdoi

The DOI for Treatment of Tourette's Syndrome with Δ<sup>9</sup>-Tetrahydrocannabinol (THC): A Randomized Crossover Trial is on the source record.

What is the PMID of Treatment of Tourette's Syndrome with Δ<sup>9</sup>-Tetrahydrocannabinol (THC): A Randomized Crossover Trial?

ScholarIQpmid

The PMID for Treatment of Tourette's Syndrome with Δ<sup>9</sup>-Tetrahydrocannabinol (THC): A Randomized Crossover Trial is on the source record.

What is the OpenAlex record for Treatment of Tourette's Syndrome with Δ<sup>9</sup>-Tetrahydrocannabinol (THC): A Randomized Crossover Trial?

ScholarIQopenalex

The OpenAlex for Treatment of Tourette's Syndrome with Δ<sup>9</sup>-Tetrahydrocannabinol (THC): A Randomized Crossover Trial is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial